Global Health Community (GH)
Applying clinical pharmacology and translational medicine principles and methodology to improve and achieve equity in the use of therapeutics and health for people worldwide.
- Adding a Global Health dimension to all ASCPT activities.
- Provide a networking platform for all members involved in Global Health within their field.
Promote innovative science to accelerate development of novel drugs globally.
Joint Infectious Diseases and Global Health Community Webinar
Title: Breaking Down Barriers for Acceleration of Development of New Anti-Infectives
Speakers: Major Jeffrey W. Froude, II, PhD, Uniformed Services University of the Health Sciences and Steven E. Kern, PhD, Bill and Melinda Gates Foundation
Moderators: Kelley E. Dooley, MD, PhD, Johns Hopkins University School of Medicine, and Matthew Rizk, PhD, Merck
Organizer: Hazem Hassan, PhD, MS, RPh, RCDS, University of Maryland School of Pharmacy
Description: This webinar will focus on the integrated research and development methods utilized by the Department of Defense for acquiring medical countermeasures. Major Jeff Froude will discuss historical success of the therapeutic developments by DTRA during the Ebola outbreak and how these lessons learned can be utilized in the future for both defense threats as well as global health countermeasure development. Dr. Kern will discuss how the Gates Foundation is working with their partners to use model-informed drug development techniques to advance the development of anti-infective agents in global health. With specific emphasis on malaria, tuberculosis, and other neglected diseases, this section will highlight challenges to new drug development for these conditions and opportunities being implemented that address these challenges and improve the potential for creating successful therapeutic solutions.
Rada Savic, PhD